Research output per year
Research output per year
Fingerprint
Dive into the research topics where Lisbeth Enggaard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
Eichhorst, B., Niemann, C. U., Kater, A. P., Fürstenau, M., von Tresckow, J., Zhang, C., Robrecht, S., Gregor, M., Juliusson, G., Thornton, P., Staber, P. B., Tadmor, T., Lindström, V., da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Nösslinger, T., Janssens, A., & 31 others, 11 May 2023, In: The New England journal of medicine. 388, 19, p. 1739-1754 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia
Vainer, N., Aarup, K., Andersen, M. A., Wind-Hansen, L., Nielsen, T., Frederiksen, H., Enggaard, L., Poulsen, C. B., Niemann, C. U. & Rotbain, E. C., 10 Mar 2023, (E-pub ahead of print) In: British Journal of Haematology.Research output: Contribution to journal › Journal article › Research › peer-review
-
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, A. O., Enggaard, L., Hansen, M., Holmström, M. O., Met, Ö., Svane, I. M., Niemann, C. U., Pedersen, L. M. & Andersen, M. H., 2022, In: Frontiers in Oncology. 12, p. 1-13 13 p., 1023015.Research output: Contribution to journal › Journal article › Research › peer-review
-
Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial
Kater, A. P., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., van der Kevie-Kersemaekers, A-M. F., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Brieghel, C., Mattsson, M., Bellido, M., Tran, H. T. T., & 2 others, Jun 2022, In: The Lancet Oncology. 23, 6, p. 818-828 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Niemann, C. U., Levin, M-D., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 25 Feb 2021, In: Blood. 137, 8, p. 1117-1120 4 p.Research output: Contribution to journal › Letter › peer-review
18 Citations (Scopus)